May 3, 2017 09:59 AM EDT

Amgen backs WuXi NextCODE’s $75M B round; ImCheck bags €20 venture round for I-O work

Shehla Shakoor

Managing Director

→ The global contract genomics outfit WuXi NextCODE raised a $75 million B round from an international consortium of investors. Amgen Ventures was involved …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amgen backs WuXi NextCODE’s $75M B round; ImCheck bags €20 venture round for I-O work

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Am­gen backs WuXi NextCODE’s $75M B round; Im­Check bags €20 ven­ture round for I-O work

Managing Director

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Amgen backs WuXi NextCODE’s $75M B round; ImCheck bags €20 venture round for I-O work